664 related articles for article (PubMed ID: 978105)
21. Anterior pituitary sensitivity in immature female rats stimulated with gonadotrophin releasing hormone in vivo: effect of priming with oestrogen, pregnant mare serum gonadotrophin or brain lesion.
De Ziegler D; Wilkinson M; Cassard D; Ruf KB
J Endocrinol; 1977 Jul; 74(1):99-109. PubMed ID: 327011
[TBL] [Abstract][Full Text] [Related]
22. Return of ovulation following a single injection of depo-medroxyprogesterone acetate: a pharmacokinetic and pharmacodynamic study.
Lan PT; Aedo AR; Landgren BM; Johannisson E; Diczfalusy E
Contraception; 1984 Jan; 29(1):1-18. PubMed ID: 6234145
[TBL] [Abstract][Full Text] [Related]
23. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
Carlström K; Lunell NO; Zador G
Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
[TBL] [Abstract][Full Text] [Related]
24. Daily serum follicle-stimulating hormone, luteinizing hormone, and plasma testosterone and androstenedione in hirsute women with polycystic sclerotic ovaries: effects of diethylstilbestrol and norethindrone acetats.
Daane TA; Dignam WJ; Frankland MV; Simmer HH; Parlow AF
Am J Obstet Gynecol; 1973 Oct; 117(3):392-9. PubMed ID: 4729733
[TBL] [Abstract][Full Text] [Related]
25. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
[TBL] [Abstract][Full Text] [Related]
26. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
[TBL] [Abstract][Full Text] [Related]
27. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate.
Furuhjelm M; Carlström K
Acta Obstet Gynecol Scand; 1977; 56(4):351-61. PubMed ID: 602703
[TBL] [Abstract][Full Text] [Related]
28. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
29. The mechanism of action of an antifertility vaccine in the rhesus monkey: reversal of the effects of antisera to the beta-subunit of ovine luteinizing hormone by medroxyprogesterone acetate.
Thau RB; Sundaram K
Fertil Steril; 1980 Mar; 33(3):317-20. PubMed ID: 6767627
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of the postcoital contraceptive effect of LH-RH in the rat. I. Serum hormone levels during chronic LH-RH Administration.
Beattie CW; Corbin A; Cole G; Corry S; Jones RC; Koch K; Tracy J
Biol Reprod; 1977 Apr; 16(3):322-32. PubMed ID: 321040
[TBL] [Abstract][Full Text] [Related]
31. Effect of norethindrone acetate released from a single silastic implant on serum FSH, LH, progesterone and estradiol-17beta of women during first eight months of treatment.
Rahman SA; Jha P; Laumas V; Jain AK; Dileepkumar ; Takkar D; Hingorani V; Laumas KR
Contraception; 1977 Nov; 16(5):487-97. PubMed ID: 590011
[TBL] [Abstract][Full Text] [Related]
32. Plasma profile on pituitary gonadotropins and ovarian steroids in women during 17 alpha-acetoxy- 11 beta-methyl-19-nor-progesterone administration.
Pérez-Palacios G; Iramain C; Castañeda E; Rojo B; Long DW; Scaglia HE; Gual C
Contraception; 1975 Jul; 12(1):37-43. PubMed ID: 1139948
[TBL] [Abstract][Full Text] [Related]
33. Effects of low dose oral contraceptives containing norethindrome and ethinyl estradiol on serum levels of progesterone and pituitary gonadotropins.
McGuire JL; Bariso CD; Yuliano E; Hume RJ; Pasquale SA
Contraception; 1975 Mar; 11(3):329-38. PubMed ID: 1116369
[TBL] [Abstract][Full Text] [Related]
34. Effect of daily administration of 0.5 mg. of chlormadinone acetate on plasma levels of follicle-stimulating hormone, luteinizing hormone, and progesterone during the menstrual cycle.
Saunders DM; Marcus SL; Saxena BB; Beling CG; Connell EB
Fertil Steril; 1971 May; 22(5):332-44. PubMed ID: 4102481
[TBL] [Abstract][Full Text] [Related]
35. On the mechanism of action of progestins.
Pérez-Palacios G; Fernández-Aparicio MA; Medina M; Zacarías-Villareal J; Ulloa-Aguirre A
Acta Endocrinol (Copenh); 1981 Jul; 97(3):320-8. PubMed ID: 6455041
[No Abstract] [Full Text] [Related]
36. Radioimmunoassay of serum medroxyprogesterone acetate (Provera) in women following oral and intravaginal administration.
Hiroi M; Stanczyk FZ; Goebelsmann U; Brenner PF; Lumkin ME; Mishell DR
Steroids; 1975 Sep; 26(3):373-86. PubMed ID: 1198624
[TBL] [Abstract][Full Text] [Related]
37. Correlation between the serum norethindrone (NET) levels attained after insertion of a silastic implant releasing norethindrone acetate and the endogenous hormones particularly progesterone.
Laumas V; Jain AK; Jha P; Rahman SA; Kumar D; Malik BK; Sarkar NN; Takkar D; Hingorani V; Laumas KR
Contraception; 1981 Feb; 23(2):211-25. PubMed ID: 6786828
[TBL] [Abstract][Full Text] [Related]
38. Regulation of human gonadotropins.
Jaffe RB; Midgley AR; Goebelsmann U; Snyder DL
Gynecol Invest; 1970; 1(3):169-78. PubMed ID: 4104708
[TBL] [Abstract][Full Text] [Related]
39. Effects of RU16117, an orally active weak oestrogenic compound, in postmenopausal women.
Faure N; Labrie F; Olivier G; Tremblay M; Cloutier D; Lemay A; Ferland L; Azadian-Boulanger G; Bouton MM; Husson JM; Raynaud JP
Maturitas; 1980 Jul; 2(2):155-68. PubMed ID: 6782429
[TBL] [Abstract][Full Text] [Related]
40. The combined use of oral medroxyprogesterone acetate and methyltestosterone in a male contraceptive trial programme.
Bain J; Rachlis V; Robert E; Khait Z
Contraception; 1980 Apr; 21(4):365-79. PubMed ID: 6771093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
